Narabayashi Hikari, Koma Chiharu, Nakata Kazuaki, Ikegami Mion, Nakanishi Yusuke, Ogihara Jun, Tsuda Masato, Hosono Akira, Hanazawa Shigemasa, Takahashi Kyoko
Department of Applied Biological Science, College of Bioresource Sciences, Nihon University, Fujisawa, Japan.
Department of Chemistry and Life Science, College of Bioresource Sciences, Nihon University, Fujisawa, Japan.
Front Mol Biosci. 2022 Oct 21;9:1005136. doi: 10.3389/fmolb.2022.1005136. eCollection 2022.
The intestine is inhabited by a large number of commensal bacteria that are immunologically non-self, potentially causing inflammation. However, in a healthy intestine, inflammation is strictly controlled at low levels to maintain homeostasis. We previously reported that the gut microbiota induce DNA methylation of the gene encoding Toll-like receptor (TLR) 4, a pattern recognition receptor that recognizes lipopolysaccharides of gram-negative bacteria, in colonic epithelial cells, suggesting its role in controlling intestinal inflammation. However, there remains a question of how gut microbiota cause methylation of only specific genes including TLR4, despite the fact that DNA methyltransferase (DNMT) is common to all genes targeted for methylation. Here, we identified RBM14 as an adaptor molecule that recruits DNMT to the TLR4 gene. RBM14 was shown to bind DNMT3 and be expressed at significantly higher levels in an intestinal epithelial cell (IEC) line with hypermethylated TLR4 gene than in an IEC line with hypomethylated TLR4 gene. In addition, RBM14 interacted with DNA regions of the TLR4 gene, and knockdown of RBM14 suppressed DNA methylation of the TLR4 gene in IECs. Furthermore, RBM14 expression was higher in colonic epithelial cells of conventional mice than in those of germ-free mice. Collectively, these results indicate that the gut microbiota induce methylation of the TLR4 gene in colonic epithelial cells by upregulating RBM14, which can recruit DNMT3 to the gene. The regulation of adaptor molecules such as RBM14, which bind to specific target genes and recruit DNMT, can explain, at least in part, how gut microbiota contribute to the maintenance of intestinal homeostasis through epigenetic control of specific gene expression in IECs.
肠道中栖息着大量共生细菌,这些细菌在免疫上属于非自身成分,可能引发炎症。然而,在健康的肠道中,炎症被严格控制在低水平以维持体内平衡。我们之前报道过,肠道微生物群可诱导结肠上皮细胞中编码Toll样受体(TLR)4的基因发生DNA甲基化,TLR4是一种识别革兰氏阴性菌脂多糖的模式识别受体,这表明其在控制肠道炎症中发挥作用。然而,尽管DNA甲基转移酶(DNMT)是所有靶向甲基化的基因所共有的,但肠道微生物群如何仅导致包括TLR4在内的特定基因发生甲基化,这一问题仍然存在。在这里,我们确定RBM14是一种衔接分子,可将DNMT招募至TLR4基因。研究表明,RBM14与DNMT3结合,并且在TLR4基因高度甲基化的肠道上皮细胞(IEC)系中的表达水平显著高于TLR4基因低甲基化的IEC系。此外,RBM14与TLR4基因的DNA区域相互作用,敲低RBM14可抑制IEC中TLR4基因的DNA甲基化。此外,常规小鼠结肠上皮细胞中的RBM14表达高于无菌小鼠。总体而言,这些结果表明,肠道微生物群通过上调RBM14来诱导结肠上皮细胞中TLR4基因的甲基化,RBM14可将DNMT3招募至该基因。像RBM14这样与特定靶基因结合并招募DNMT的衔接分子的调控,至少可以部分解释肠道微生物群如何通过对IEC中特定基因表达的表观遗传控制来促进肠道体内平衡的维持。